Aurora Integrated Oncology Foundation

“Aiof is in the process of adopting and approving a written whistleblower and a written document retention and destruction policy which will be approved in 2024.”

“AIOF was formed on April 14, 2022 with a stated purpose of improving the quality of and access to oncology care to residents of Alaska. On December 27, 2023, AIOF acquired four radiation oncology centers located in the State of Alaska, including through the acquisition of membership interests in certain limited liability companies that owned the centers (the "LLCs") or through the direct acquisition of such assets from the owners thereof (the "Transaction"). As noted in AIOF's Form 1023 - "Application for Recognition of Exemption Under Section 501(c)(3) of the Internal Revenue Code," the initial Board of Directors included three individuals who were then part owners of the LLCs. The Form 1023 further noted the AIOF "is working on replacing some of its Board of Directors to reflect a diverse, community-based governing board." As described in the Form 1023, the following five new Board members were recruited and replaced the initial Board of Directors on January 12, 2023: William Popp, President of Anchorage Economic Development Corporation Michele Brown, Senior Fellow at Rasmuson Foundation Donna Galbreath, M.D., Senior Medical Director of Quality Assurance, Southcentral Foundation Greg Merrill, President of Radiation Billing Solutions, Inc. William Magnuson, M.D., Oncologist In accordance with AIOF's conflict of interest policy, Dr. Magnuson (part-owner of certain LLCs) and Mr. Merrill (part owner of the proposed post-Transaction manager of the facilities) were not involved in any of the discussions or approvals relating to the Transaction. The Board created a Transaction Committee consisting solely of the three non-interested Board members (i.e., Mr. Popp, Ms. Brown and Dr. Galbreath) to review and approve the Transaction.”

“Sherrie W Hinshaw, Raymond S Frech, Daniel Moore, and Greg Merrill - Business relationship, Eugene Huang, John Halligan, William Magnuson, Daniel Moore, and Greg Merrill - Business relationship”

“Radiation Billing Solutions, Inc. (RBS) provides comprehensive management functions to Aurora Integrated Oncology Foundation (AIOF) which include the following: compliance program services, health information services, clinical and non-clinical management services, accounting services, regulatory reporting support services, facilities management services, financial planning and analysis services, human resource services, information technology management services, supply chain services, revenue cycle services, executive management & marketing services, and nursing management services. The management services agreement requires RBS to conduct business and operations on AIOF's behalf in a manner consistent with the charitable purposes required under section 501(C)(3) of the code and in line with policies adopted by the AIOF. The following individuals were employed by RBS: Raymond S. Frech, Director of AIOF; Reportable Compensation $124,775 ; Other Reportable Compensation $26,068 Greg Merrill, Director of AIOF; Reportable compensation $181,036; Other Reportable Compensation $38,023 Daniel Moore, Director of AIOF; Reportable Compensation $51,882; Other Reportable Compensation $6,578”

“There are no other committees that can act on behalf of the governing body.”

“An independent accounting firm prepares and reviews the 990. The 990 is then reviewed by the finance committee. Any questions or concerns the finance committee has are addressed and any corrections or clarifications that need to be made are made. A copy of the 990 is then presented to the board of directors prior to filing.”

“The aiof board of directors has adopted a conflict of interest (coi) policy as well as a code of conduct, which requires board of directors, officers and key employees to annually disclose interests that could give rise to conflicts. The coi policy is also documented in the bylaws, and includes a definition of what constitutes a conflict of interest, required disclosure of those conflicts, and ensuring the board approves only contracts that are considered fair, reasonable, and in the aiof's best interests. Conflicts are reviewed at the board level and the board chair determines whether a conflict exists. Individuals with conflicts do not participate in voting.”

“AIOF has articulated in the bylaws of the organization as well as through adoption of a suite of policies to ensure no more than fair and reasonable compensation is paid. These policies include: Physician Contracting and Compensation Review Policy, Board Compensation Policy, as well as an Executive and Disqualified Persons policy. The Executive & Disqualified Persons policy requires that reasonable compensation be paid to any disqualified persons, with board approval required. Physician compensation was determined by a third-party valuation firm prior to the execution of contracts in 2023. Board compensation was set through a benchmarking analysis and legal consultation in 2024. President/CEO compensation was determined through benchmarking analysis in 2023 and updated by a third-party valuation firm in 2024. The management fee was confirmed by a third-party valuation firm prior to the execution of the management agreement in 2023.”

“Aiof makes all required disclosures available to the public under irs regulations.”

“Anchorage Radiation Oncology Center, Mat-Su Valley Cancer Care, Peninsula Radiation Oncology Center and Southeast Radiation Oncology Center focuses on accessible, advanced treatment and comprehensive support for patients and families. With a commitment to patient-centered care, AIOF emphasizes reinvestment in community health initiatives and state-of-the-art services, operating under a sustainable model that covers all residents of Alaska, regardless of their insurance status.”